Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Descriptor ID |
D005833
|
| MeSH Number(s) |
C04.588.945.418 C13.351.937.418
|
| Concept/Terms |
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
|
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in this website by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 1 | 3 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 4 | 0 | 4 |
| 2018 | 4 | 0 | 4 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Advances in antibody-drug conjugates for gynecologic malignancies. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):6-14.
-
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation. Gynecol Oncol. 2021 07; 162(1):203-209.
-
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021 02; 160(2):625-632.
-
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol. 2021 01; 160(1):244-251.
-
Gynecologic Oncology in the Department of Defense. Semin Reprod Med. 2019 09; 37(5-06):222-226.
-
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol. 2020 07; 158(1):16-24.
-
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity. Gynecol Oncol. 2020 06; 157(3):729-732.
-
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). Gynecol Oncol. 2019 12; 155(3):452-460.
-
Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy. Med Dosim. 2020 Spring; 45(1):21-27.
-
New and Novel Therapies for Gynecologic Cancers. Semin Oncol Nurs. 2019 Apr; 35(2):217-219.